 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||| LAB150 / Evotec, Toronto Innovation Acceleration Partners
Licensing / partnership: $EVO TIAP and Evotec Expand LAB150 BRIDGE Partnership to Include Amgen https://t.co/SmNqp1yFT4 (Twitter) - Oct 17, 2022
- | LAB150 / Evotec, Toronto Innovation Acceleration Partners
Journal: Occupational exposure to physicians working with a Zero-Gravity™ protection system in haemodynamic and electrophysiology labs and the assessment of its performance against a standard ceiling suspended shield. (Pubmed Central) - Apr 23, 2022
The skin doses to hands and ankles non-protected by the ZG were 5 µSv for the most exposed left finger and left ankle in electrophysiology lab, while in haemodynamic lab 150 µSv and 17 µSv, respectively...The study results indicate that ZG performance is superior to CSS. It can be simultaneously used with the ceiling suspended lead shield to ensure the protection to the hands as long as this is not obstructive for the work.